A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Study ID
- NCT06851559
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Vonoprazan — DRUGVonoprazan will be administered orally as a tablet
- Placebo — DRUGPlacebo will be administered orally as tablet
Study Details
The primary objective of this study is to assess the efficacy of vonoprazan 20 mg once daily (QD) compared to placebo QD in the number of participants with a peak eosinophilic histologic response \<15 eosinophils per high-power field (eos/hpf) after 12 weeks of therapy.
Key Dates
- Start date
- Oct 30, 2025
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Vonoprazan 20 mgParticipants will be administered vonoprazan at a dose of 20 mg for 12 weeks. Participants will continue to receive the same dose for an additional 12 weeks.
- Experimental: PlaceboParticipants will be administered placebo for 12 weeks. Participants will then receive vonoprazan 20 mg for an additional 12 weeks.
Primary Outcome Measure
Number of Participants at Week 12 Achieving Peak Esophageal Intraepithelial Eosinophil Count <15 eos/hpf. [ Time Frame: Week 12 ]
Central Contacts
- Phathom Medical Information1-888-775-PHAT (7428)
Locations (41)
Find similar trials in Little Rock, AR
By research site
Preferred Research Partners, Inc· Little Rock, ARGW Research, Inc· Chula Vista, CASouthern California Research Institute Medical Group· Los Angeles, CARocky Mountain Gastroenterology· Lakewood, COWestern States Clinical Research, Inc.· Wheat Ridge, COConnecticut Clinical Research Institute· Bristol, CT
Related Studies
- Molecular Basis of Food AllergyEnrolling By Invitation · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Natural History and Genetics of Food Allergy and Related ConditionsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruiting · Children's Hospital Medical Center, Cincinnati · Phoenix, Arizona
- Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)Recruiting · University of California, San Diego · San Diego, California